Clinical Trial Update: Women's Angiographic Vitamin and Estrogen Trial (WAVE) [Phase 3]

View source ↗

Summary

Phase 3 trial in postmenopausal women evaluating estrogen plus a vitamin treatment for cardiovascular outcomes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Status: COMPLETED